Oxford Nanopore Technologies plc (ONTTF)
USD 1.65
(1.85%)
USD 1.65
(1.85%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 777.06 Million GBP | -5.68% |
| 2022 | 823.89 Million GBP | -2.14% |
| 2021 | 841.86 Million GBP | 199.37% |
| 2020 | 281.2 Million GBP | 70.7% |
| 2019 | 164.73 Million GBP | -5.97% |
| 2018 | 175.18 Million GBP | 46.84% |
| 2017 | 119.3 Million GBP | -24.94% |
| 2016 | 158.94 Million GBP | 46.13% |
| 2015 | 108.77 Million GBP | 54.72% |
| 2014 | 70.3 Million GBP | 2.08% |
| 2013 | 68.87 Million GBP | 32.58% |
| 2012 | 51.94 Million GBP | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 722.65 Million GBP | 0.0% |
| 2023 Q4 | 777.06 Million GBP | 0.0% |
| 2023 FY | 777.06 Million GBP | -5.68% |
| 2023 Q1 | 758.82 Million GBP | -7.9% |
| 2023 Q2 | 758.82 Million GBP | 0.0% |
| 2023 Q3 | 777.06 Million GBP | 2.4% |
| 2022 Q4 | 823.89 Million GBP | 0.0% |
| 2022 FY | 823.89 Million GBP | -2.14% |
| 2022 Q3 | 823.89 Million GBP | -2.18% |
| 2022 Q2 | 842.28 Million GBP | 0.0% |
| 2022 Q1 | 842.28 Million GBP | 0.05% |
| 2021 Q4 | 841.86 Million GBP | 0.0% |
| 2021 FY | 841.86 Million GBP | 199.37% |
| 2021 Q1 | 436.48 Million GBP | 55.22% |
| 2021 Q2 | 436.48 Million GBP | 0.0% |
| 2021 Q3 | 841.86 Million GBP | 92.87% |
| 2020 Q4 | 281.2 Million GBP | 0.0% |
| 2020 FY | 281.2 Million GBP | 70.7% |
| 2020 Q3 | 281.2 Million GBP | 0.0% |
| 2020 Q1 | - GBP | 0.0% |
| 2019 FY | 164.73 Million GBP | -5.97% |
| 2018 FY | 175.18 Million GBP | 46.84% |
| 2017 FY | 119.3 Million GBP | -24.94% |
| 2016 FY | 158.94 Million GBP | 46.13% |
| 2015 FY | 108.77 Million GBP | 54.72% |
| 2014 FY | 70.3 Million GBP | 2.08% |
| 2013 FY | 68.87 Million GBP | 32.58% |
| 2012 FY | 51.94 Million GBP | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bioxytran, Inc. | 137.63 Thousand USD | -564469.378% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -1900.314% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -1017609.616% |
| SQZ Biotechnologies Company | 107.18 Million USD | -624.959% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -54162.894% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -7262.725% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -496.773% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -1073709.162% |
| Marizyme, Inc. | 22.01 Million USD | -3429.681% |
| Genus plc | 1.02 Billion USD | 24.476% |
| Pharming Group N.V. | 462.85 Million USD | -67.885% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -23354.85% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -155611.678% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -123833.333% |
| ContraFect Corporation | 20.67 Million USD | -3657.735% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -203225.161% |
| IMV Inc. | 31.33 Million USD | -2379.949% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -18642.351% |
| ONE Bio Corp. | 70.08 Million USD | -1008.734% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -504.67% |
| Mesoblast Limited | 667.9 Million USD | -16.344% |
| MultiCell Technologies, Inc. | 126.22 USD | -615640844.383% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -2108.88% |
| Genscript Biotech Corporation | 3.38 Billion USD | 77.053% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -100732.81% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -297309.263% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -10662.986% |
| Biomind Labs Inc. | 73.81 Thousand USD | -1052558.53% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -53533.278% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -2488.916% |
| Skye Bioscience, Inc. | 11.94 Million USD | -6407.833% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -57106.19% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -28194.509% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -198959.857% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -39582.686% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -112929.502% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -82593.529% |
| EV Biologics, Inc. | 431.71 Thousand USD | -179894.626% |
| Q BioMed Inc. | 3.51 Million USD | -22003.776% |
| GB Sciences, Inc. | 103.44 Thousand USD | -751105.506% |
| Alpha Cognition Inc. | 2.45 Million USD | -31588.749% |
| CSL Limited | 38.02 Billion USD | 97.956% |
| Agentix Corp. | 261.39 Thousand USD | -297178.417% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -74.109% |
| Enzolytics Inc. | 361.7 Million USD | -114.832% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | 8.11 Million USD | -9475.625% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -41279.747% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -29750.307% |
| argenx SE | 4.54 Billion USD | 82.893% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -2680.783% |
| HST Global, Inc. | 1526.00 USD | -50921394.102% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -1528.992% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -78552.627% |
| Halberd Corporation | 10.13 Thousand USD | -7670041.151% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -121381.234% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -8583.077% |
| Zenith Capital Corp. | 7410.00 USD | -10486566.667% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -3410909.174% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -241369.084% |
| AVAX Technologies, Inc. | 7.37 Million USD | -10433.353% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -297210.265% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -83638.648% |
| Ember Therapeutics, Inc. | 184.00 USD | -422316204.348% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 62.24 Thousand USD | -1248232.477% |
| Helix BioMedix, Inc. | 3.02 Million USD | -25587.27% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -1374.473% |
| Kadimastem Ltd | 2.3 Million USD | -33625.478% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 14.56 Million USD | -5236.858% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -1360922.174% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -33638947.619% |
| LadRx Corporation | 2.3 Million USD | -33569.919% |
| Cell Source, Inc. | 195.17 Thousand USD | -398044.192% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -161600.277% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -219646.788% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -219646.788% |
| Affymax, Inc. | 7.44 Million USD | -10340.172% |
| Mobile Lads Corp. | 52.00 USD | -1494349900.0% |
| Itoco Inc. | 1.4 Million USD | -55401.574% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -812242.014% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -732977.358% |
| International Stem Cell Corporation | 5.39 Million USD | -14316.735% |
| CytoDyn Inc. | 11.13 Million USD | -6877.927% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -543406.421% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -4345884.34% |
| Qrons Inc. | 420.00 USD | -185014661.905% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -201487.668% |
| SYBLEU INC | 330.46 Thousand USD | -235039.862% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -140641.505% |
| Rebus Holdings, Inc. | 5000.00 USD | -15541140.0% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -189694.882% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -5079.781% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -4587.026% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -983522.785% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -89767.315% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -10237.395% |
| Neutra Corp. | 2851.00 USD | -27255669.905% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -2297.895% |
| PureTech Health plc | 693.97 Million USD | -11.973% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -9527.722% |
| IXICO plc | 15.84 Million USD | -4804.486% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -9282.54% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -652.063% |
| CSL Limited | 38.02 Billion USD | 97.956% |
| Cellectis S.A. | 333.99 Million USD | -132.657% |